Skip to content

Cystoinflation to Prevent Bladder Injury in Obstetrics and Gynaecology Surgery

Cystoinflation to Prevent Bladder Injury in Obstetrics and Gynaecology Surgery Part 1-Cystoinflation in Repeat C-section Part 2- Cystoinflation in Abdominal Hysterectomy Part3- Cystoinflation in Placenta Accreta Spectrum Management

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04302545
Enrollment
564
Registered
2020-03-10
Start date
2017-08-01
Completion date
2022-04-30
Last updated
2024-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesions Pelvic, Bladder Injury, Complications; Cesarean Section

Brief summary

Part1:The healthy pregnant women with previous operative deliveries admitted for elective C-section will be counselled and conditioned informed consent will be taken to be included in either study group if dense pelvic adhesions will be found during their operation. Adhesiolysis will be performed using bladder retro-fill with 300cc saline in the cystoinflation group, and without retro-fill in control.Both groups will be observed for bladder injury rate,bloodloss,operativetime,urinary tract infection,micturition problems and fistula formation. Part2&3:Summary of Part 2 and 3 will be provided after publication

Detailed description

Part1:Investigators will conduct this study to find the effectiveness of cystoinflation to prevent bladder injury in women with adhesions of previous C-sections. This prospective analytic longitudinal study will be conducted in Lady Willingdon Hospital, a tertiary care teaching hospital affiliated with King Edward Medical University Pakistan, from August 2017 to July 2019, after approval by the institutional review board of King Edward Medical University, Pakistan. The subjects will be randomly allocated to cystoinflation and control groups. The healthy pregnant women with previous operative deliveries admitted for elective C-section will be counselled and conditioned informed consent will be taken to be included in either study group if dense pelvic adhesions will be found during their operation. Adhesiolysis will be performed using bladder retro-fill with 300cc saline in the cystoinflation group, and without retro-fill in control. We will assess primary outcome by observing bladder injury rate, blood loss and operative time. The secondary outcome will be assessed by Urinary tract infection, micturition problems and fistula formation during 3month follow up period. The cystoinflation will be considered effective if the proportion of bladder injury in the study group will be less than 50% of the control group. Part2&3:Details of part2&3 will be provided after publication

Interventions

PROCEDURECystoinflation

Bladder retrofill with 300cc saline to distend the bladder to recognize bladder outline

Sponsors

King Edward Medical University
CollaboratorOTHER
Institute of Public Health, Pakistan
CollaboratorOTHER
Shazia Saaqib
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The participants and outcome assessors are kept blind by just entering the random number assigned to the subject on the papers and notes are written without details of adhesiolysis. The completed outcome performas are sent to the assessors with the only random number entered and without the assigned group. The random number file is opened only after receiving results from the statistician. The care providers in theatre and principle surgeon cannot be blinded in this study.

Intervention model description

Subjects will be assigned into cystoinflation group and control group after parallel assignment. In the cystoinflation group, the intervention will be retro-fill of the bladder with 300cc saline and clamping the drainage port of the catheter till the completion of adhesiolysis. In contrast, the urinary catheter of control group patients will be put on free drainage.

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

Part1:Inclusion Criteria: * • Healthy pregnant women of any age * Two or more previous C-sections * Gestational age between 38-40 weeks (confirmed by dating scan) * Dense Adhesions of Tulandi scores four or more. * women who give informed consent to participate in the study

Exclusion criteria

:• Patients with medical disorders * Bladder injury before group assignment * Placenta previa * Subjects experiencing micturition problems (dysuria, frequency, urgency, urinary retention, incontinence) before the study. Eligibility criteria of part 2&3 will be provided after publication -

Design outcomes

Primary

MeasureTime frameDescription
Bladder Injury RateFrom the confirmation of adhesions to adhesiolysis and separation of bladder flap from uterus, before delivery of the baby during cesarean section.This time frame can range between 10-20 minutes.The bladder injury will be detected by direct visualization in the cesarean section before delivery of the baby during adhesiolysis of dense adhesions of the lower uterine segment, which cover and obscure the bladder. The bladder injury outcome will be measured as the number(percentage) of subjects with injury.
Blood LossFrom the confirmation of adhesions to adhesiolysis and separation of bladder flap from uterus, before delivery of the baby during cesarean section.This time frame can range between 10-20 minutes.Amount of blood loss during C-section will be increase in weight of sponges used during operation, taking 1gram equal to 1cc.
Operative TimeDuring Caesarean sectionTime from incision till closure of skin

Secondary

MeasureTime frameDescription
Postmicturition Bladder Volume After C-sectionupto 3monthsVolume of urine retained in bladder after evacuation. Bladder distension will be diagnosed if volume retained in the bladder will be greater than 50cc measured on 4th postoperative day
Composite Micturition Problems During Hospital StayComplaint recorded during hospital stay (range between 4-21 days)The micturition problems during the hospital stay investigated in this study were dysuria, feeling of incomplete evacuation, frequency, urgency, urethral and extra-urethral incontinence), Dysuria was expressed by the subject as painful micturition using an 11point visual analogue Scale from zero to ten and converted into severity scores from 0-3. Score 0 or no point= 0 point on scale Score1 or mild pain=1-3point Score2 or Moderate Pain=4-6points; Score 3 or Severe Pain=.7-10 Other micturition problems (feeling of incomplete evacuation, frequency, urgency, urethral and extra-urethral incontinence) were measured subjectively on a 4point Likert scale questionnaire according to severity ranging from 0-3 (0-never, 1-rarely, 2-sometimes, and 3-often). The micturition problems of each subject were summed up as composite variables and both groups were compared for the mean value of the composite variable and standard deviation in spss20 statistical software.
Duration of Urinary Catheterizationupto 3monthsThe time interval for which subject will be kept catheterized postoperatively.
White Blood Cells Count Per High Power Feild3rd postoperative dayThe normal white cell count ranges between 4000-11000 per microlitre. The raised count is an indication of postoperative infection.
Number of Subjects With Urinary Fistula Formationupto 3monthsabnormal communication between genital tract nd urinary tract
Composite Micturition Problems After Dischargeupto 3monthsIT is composit Likert score(range from 0-3) of micturition problems recorded by patient after discharge from the hospital to the completion of 3months postoperative(follow up period).The lower value of the score is associated with good outcome while higher value shows a poor outcome.
Duration of Hospital Stayupto 3monthsThe time interval in days from the date of operation till discharge from the hospital.
Urine Culture Report for Micro-organisms2nd postoperative dayThe outcome measure was the number(percentage) of subjects in which urine culture reports showed the growth of micro-organisms in the urine of the subjects sent for test on the second postoperative day.
Feverupto 3monthsNumber of patients who presented with fever during hospital stay

Countries

Pakistan

Participant flow

Recruitment details

The study was carried out in King Edward Medical University affiliated hospital/Lady Willingdon Hospital for a period of two years starting from August 1,2017 to July31,2019 including a 3month follow up period.

Pre-assignment details

Subjects admitted with full term pregnancy and previous 2 C-sections n=734 The study subjects were selected in two step assessment(a)preoperative (during operation). preoperatively Excluded n=346 due to medical disorders, placenta previa, bladder injury before group assignment, micturition problems before operation Declined to participate=5 During operation Excluded=174 as criteria of dense adhesions of bladder was not met with.

Participants by arm

ArmCount
Cystoinflation Group
Cystoinflation: Bladder will be retro-filled with 300cc saline to distend the bladder to recognize bladder outline in cystoinflation group whenever dense adhesions will be encountered which obscure the bladder either before or after opening the peritoneal cavity. Bladder outline will be recognized by observing its gradual distension during bladder retro-fill .The outcome of cystoinflation group will be divided into distension arm(no bladder injury arm) and bladder injury arm.
107
Control Group
In control group,Pelvic adhesiolysis will be performed with bladder put on free drainage by urinary catheter.The outcome of control arm will be divided into distension arm(no bladder injury arm) and bladder injury arm.
107
Total214

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up34

Baseline characteristics

CharacteristicCystoinflation GroupControl GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
107 Participants107 Participants214 Participants
Age, Continuous32.19 years
STANDARD_DEVIATION 2.3
31.73 years
STANDARD_DEVIATION 2.4
31.96 years
STANDARD_DEVIATION 2.388
BMI kg/m^230.73 kg/m^2
STANDARD_DEVIATION 1.89
30.54 kg/m^2
STANDARD_DEVIATION 1.86
30.635 kg/m^2
STANDARD_DEVIATION 1.876
Number of previous C-sections
previous2
46 Participants43 Participants89 Participants
Number of previous C-sections
previous3
52 Participants54 Participants106 Participants
Number of previous C-sections
previous4
6 Participants7 Participants13 Participants
Number of previous C-sections
previous5
3 Participants3 Participants6 Participants
Parity
para2
35 Participants33 Participants68 Participants
Parity
para3
60 Participants60 Participants120 Participants
Parity
para4
10 Participants10 Participants20 Participants
Parity
para5
2 Participants4 Participants6 Participants
Preoperative postmicturition bladder volume15 ml20 ml15 ml
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
107 Participants107 Participants214 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Region of Enrollment
Pakistan
107 participants107 participants207 participants
Score of adhesions
16
16 Participants15 Participants31 Participants
Score of adhesions
4
53 Participants56 Participants109 Participants
Score of adhesions
8
38 Participants36 Participants74 Participants
Sex: Female, Male
Female
107 Participants107 Participants214 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants
Socioecnomic status
high (per capita family income Rupees 5,000/month
13 Participants12 Participants25 Participants
Socioecnomic status
low (per capita family income <Rupees3000/month)
39 Participants41 Participants80 Participants
Socioecnomic status
medium (per capita family income<Rupees3000-5000/month
55 Participants54 Participants109 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1070 / 107
other
Total, other adverse events
0 / 1071 / 107
serious
Total, serious adverse events
3 / 10722 / 107

Outcome results

Primary

Bladder Injury Rate

The bladder injury will be detected by direct visualization in the cesarean section before delivery of the baby during adhesiolysis of dense adhesions of the lower uterine segment, which cover and obscure the bladder. The bladder injury outcome will be measured as the number(percentage) of subjects with injury.

Time frame: From the confirmation of adhesions to adhesiolysis and separation of bladder flap from uterus, before delivery of the baby during cesarean section.This time frame can range between 10-20 minutes.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Cystoinflation GroupBladder Injury Rate3 Participants
Control GroupBladder Injury Rate22 Participants
Comparison: Null Hypothesis: During the cesarean section of women with adhesions of the previous cesarean section that obscure the bladder, the bladder injury rate is not significantly decreased in cystoinflation group compared to the control.~In this study, the bladder injury rate was seven times lesser in cystoinflation group compared to the control, thereby strongly supporting our hypothesis. The power of the study for bladder injury was 0.988, calculated with statistical software G'Power version 3.1.p-value: <0.000195% CI: [-0.261, -0.094]Regression, Linear
Primary

Blood Loss

Amount of blood loss during C-section will be increase in weight of sponges used during operation, taking 1gram equal to 1cc.

Time frame: From the confirmation of adhesions to adhesiolysis and separation of bladder flap from uterus, before delivery of the baby during cesarean section.This time frame can range between 10-20 minutes.

ArmMeasureValue (MEAN)Dispersion
Cystoinflation GroupBlood Loss585.32 mlStandard Deviation 152.52
Control GroupBlood Loss797.10 mlStandard Deviation 385.09
p-value: <0.000195% CI: [-290.7, -132.84]Regression, Linear
Primary

Operative Time

Time from incision till closure of skin

Time frame: During Caesarean section

ArmMeasureValue (MEAN)Dispersion
Cystoinflation GroupOperative Time45 minutesStandard Deviation 8.66
Control GroupOperative Time45 minutesStandard Deviation 16.99
Comparison: Null Hypothsis:Cystoinflation is ineffective to prevent bladder injury in adhesions of previous C-section.The cystoinflation was to be cosidered ineffective if proportion of bladder injury in study group was less than %0% of the control.The power of the study for bladder injury prevention was.988,calculated with statistical software G'Power version3.1.p-value: 195% CI: [-3.634, 3.634]Regression, Linear
Secondary

Composite Micturition Problems After Discharge

IT is composit Likert score(range from 0-3) of micturition problems recorded by patient after discharge from the hospital to the completion of 3months postoperative(follow up period).The lower value of the score is associated with good outcome while higher value shows a poor outcome.

Time frame: upto 3months

ArmMeasureValue (MEAN)Dispersion
Cystoinflation GroupComposite Micturition Problems After Discharge.0047 scoreStandard Deviation 0.034
Control GroupComposite Micturition Problems After Discharge.0701 scoreStandard Deviation 0.222
p-value: 0.00395% CI: [-0.108, -0.023]Regression, Linear
Secondary

Composite Micturition Problems During Hospital Stay

The micturition problems during the hospital stay investigated in this study were dysuria, feeling of incomplete evacuation, frequency, urgency, urethral and extra-urethral incontinence), Dysuria was expressed by the subject as painful micturition using an 11point visual analogue Scale from zero to ten and converted into severity scores from 0-3. Score 0 or no point= 0 point on scale Score1 or mild pain=1-3point Score2 or Moderate Pain=4-6points; Score 3 or Severe Pain=.7-10 Other micturition problems (feeling of incomplete evacuation, frequency, urgency, urethral and extra-urethral incontinence) were measured subjectively on a 4point Likert scale questionnaire according to severity ranging from 0-3 (0-never, 1-rarely, 2-sometimes, and 3-often). The micturition problems of each subject were summed up as composite variables and both groups were compared for the mean value of the composite variable and standard deviation in spss20 statistical software.

Time frame: Complaint recorded during hospital stay (range between 4-21 days)

Population: Subjects of both cystoinflation and control groups during the postoperative hospital stay.

ArmMeasureValue (MEAN)Dispersion
Cystoinflation GroupComposite Micturition Problems During Hospital Stay.077 scoreStandard Deviation 0.633
Control GroupComposite Micturition Problems During Hospital Stay.47 scoreStandard Deviation 1.63
p-value: 0.02195% CI: [-0.725, -0.06]Regression, Linear
Secondary

Duration of Hospital Stay

The time interval in days from the date of operation till discharge from the hospital.

Time frame: upto 3months

ArmMeasureValue (MEAN)Dispersion
Cystoinflation GroupDuration of Hospital Stay4.18 DaysStandard Deviation 1.156
Control GroupDuration of Hospital Stay5.50 DaysStandard Deviation 3.506
p-value: <0.000195% CI: [-2.021, -0.614]Regression, Linear
Secondary

Duration of Urinary Catheterization

The time interval for which subject will be kept catheterized postoperatively.

Time frame: upto 3months

ArmMeasureValue (MEAN)Dispersion
Cystoinflation GroupDuration of Urinary Catheterization1.25 DaysStandard Deviation 1.626
Control GroupDuration of Urinary Catheterization3.14 DaysStandard Deviation 4.575
p-value: <0.000195% CI: [-2.813, -0.963]Regression, Linear
Secondary

Fever

Number of patients who presented with fever during hospital stay

Time frame: upto 3months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Cystoinflation GroupFever2 Participants
Control GroupFever13 Participants
p-value: 0.00395% CI: [-0.171, -0.035]Regression, Linear
Secondary

Number of Subjects With Urinary Fistula Formation

abnormal communication between genital tract nd urinary tract

Time frame: upto 3months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Cystoinflation GroupNumber of Subjects With Urinary Fistula Formation0 Participants
Control GroupNumber of Subjects With Urinary Fistula Formation1 Participants
Secondary

Postmicturition Bladder Volume After C-section

Volume of urine retained in bladder after evacuation. Bladder distension will be diagnosed if volume retained in the bladder will be greater than 50cc measured on 4th postoperative day

Time frame: upto 3months

ArmMeasureValue (MEAN)Dispersion
Cystoinflation GroupPostmicturition Bladder Volume After C-section15.56 mlStandard Deviation 4.968
Control GroupPostmicturition Bladder Volume After C-section14.91 mlStandard Deviation 4.952
p-value: 0.33695% CI: [-0.682, 1.991]Regression, Linear
Secondary

Urine Culture Report for Micro-organisms

The outcome measure was the number(percentage) of subjects in which urine culture reports showed the growth of micro-organisms in the urine of the subjects sent for test on the second postoperative day.

Time frame: 2nd postoperative day

Population: The population included all cases of both cystinflation group and control group.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Cystoinflation GroupUrine Culture Report for Micro-organisms2 Participants
Control GroupUrine Culture Report for Micro-organisms18 Participants
p-value: <0.000195% CI: [-0.226, -0.073]Regression, Linear
Secondary

White Blood Cells Count Per High Power Feild

The normal white cell count ranges between 4000-11000 per microlitre. The raised count is an indication of postoperative infection.

Time frame: 3rd postoperative day

Population: This analysis will be carried out in postoperative subjects of both groups.

ArmMeasureValue (MEAN)Dispersion
Cystoinflation GroupWhite Blood Cells Count Per High Power Feild6.26 count/hpfStandard Deviation 1.003
Control GroupWhite Blood Cells Count Per High Power Feild7.36 count/hpfStandard Deviation 3.063
p-value: 0.00195% CI: [-1.708, -0.479]Regression, Linear

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026